Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study

Background: Transarterial chemoembolization (TACE) is reserved for the treatment of intermediate hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer stage B); however, it can also be utilized as a neoadjuvant treatment prior to surgical resection in resectable HCC cases. This study aimed t...

詳細記述

書誌詳細

主要な著者:	Pipit Burasakarn, Sermsak Hongjinda, Anuparp Thienhiran, Nichaphat Phancharoenkit, Pusit Fuengfoo
フォーマット:	Artigo
言語:	Inglês
出版事項:	Society of Gastrointestinal Intervention 2023-10-01
シリーズ:	International Journal of Gastrointestinal Intervention
主題:	carcinoma hepatocellular; chemoembolization therapeutic; general surgery; survival; treatment outcome
オンライン･アクセス:	https://www.ijgii.org/journal/view.html?doi=10.18528/ijgii230025
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!